Mark E. Johnson

2.1k citations

32 papers · 1.8k indexed · h-index 20

Impact in

Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
Dermatology top 2%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies

Papers in ⓘ

Pharmaceutical Science 3
Hepatology 3
- Liver physiology and pathology 3

Co-authors: Daniel Blankschtein (4 shared papers)Sjoerd H. van der Burg (1 shared paper)Grayson B. Lipford (1 shared paper)Rienk Offringa (1 shared paper)Cornelis J.M. Melief (1 shared paper)Jan Nouta (1 shared paper)Samir Mitragotri (2 shared papers)Zhibin Guan (6 shared papers)
Journals: Journal of Pharmaceutical Sciences (3 papers)Cancer (2 papers)Life Sciences (2 papers)Biophysical Journal (2 papers)FEBS Journal (1 paper)
Partner nations: United States Germany Spain

In The Last Decade

Mark E. Johnson

31 papers receiving 1.7k citations

Peers

Countries citing papers authored by Mark E. Johnson

Since Specialization

Citations

This map shows the geographic impact of Mark E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Johnson more than expected).

Fields of papers citing papers by Mark E. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Johnson. The network helps show where Mark E. Johnson may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Johnson Line = papers co-authored together Mark E. Johnson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides The Journal of Immunology ·Sander Zwaveling, Sandra C. Ferreira Mota, Jan Nouta, Mark E. Johnson, Grayson B. Lipford, Rienk Offringa, Sjoerd H. van der Burg, Cornelis J.M. Melief	2002	350
2	Evaluation of Solute Permeation through the Stratum Corneum: Lateral Bilayer Diffusion as the Primary Transport Mechanism Journal of Pharmaceutical Sciences ·Mark E. Johnson, Daniel Blankschtein, Robert Langer	1997	250
3	Frequent amplification and rearrangement of chromosomal bands 6p12‐p21 and 17p11.2 in osteosarcoma Genes Chromosomes and Cancer ·Ching C. Lau, Charles P. Harris, Xinyan Lu, László Perlaky, S.K. Gogineni, Murali Chintagumpala, John Hicks, Mark E. Johnson, Nelson Davino, Andrew G. Huvos, Paul A. Meyers, John Healy, Richard Görlick, Pulivarthi H. Rao	2003	118
4	Expression Profiles of Osteosarcoma That Can Predict Response to Chemotherapy Cancer Research ·Tsz‐Kwong Man, Murali Chintagumpala, Jaya Visvanathan, Jianhe Shen, László Perlaky, John Hicks, Mark E. Johnson, Nelson Davino, Jeffrey C. Murray, Lee J. Helman, William H. Meyer, Timothy J. Triche, Kwong‐Kwok Wong, Ching C. Lau	2005	107
5	Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells Hepatology ·Mark E. Johnson, George Koukoulis, Kunio Matsumoto, Toshikazu Nakamura, Anand Iyer	1993	104
6	Synergistic Effects of Chemical Enhancers and Therapeutic Ultrasound on Transdermal Drug Delivery Journal of Pharmaceutical Sciences ·Mark E. Johnson, Samir Mitragotri, Ashish Patel, Daniel Blankschtein, Robert Langer	1996	98
7	Expression of Bcl‐2 Family Proteins in Advanced Laryngeal Squamous Cell Carcinoma: Correlation With Response to Chemotherapy and Organ Preservation The Laryngoscope ·Douglas K. Trask, Gregory T. Wolf, Carol R. Bradford, Susan G. Fisher, Kenneth O. Devaney, Mark E. Johnson, Timothy P. Singleton, Max S. Wicha	2002	89
8	Permeation of Steroids through Human Skin Journal of Pharmaceutical Sciences ·Mark E. Johnson, Daniel Blankschtein, Robert Langer	1995	82
9	An Analysis of the Size Selectivity of Solute Partitioning, Diffusion, and Permeation across Lipid Bilayers Biophysical Journal ·Samir Mitragotri, Mark E. Johnson, Daniel Blankschtein, Róbert Langer	1999	72
10	Structure-Based Design of Dendritic Peptide Bolaamphiphiles for siRNA Delivery ACS Central Science ·Hanxiang Zeng, Mark E. Johnson, Nathan J. Oldenhuis, Timothy N. Tiambeng, Zhibin Guan	2015	58
11	Altered p53 is associated with aggressive behavior of chondrosarcoma Cancer ·Yumi Oshiro, Vijaya Chaturvedi, Dorothy Hayden, Tipu Nazeer, Mark E. Johnson, Dennis A. Johnston, Nelson G. Ord��ez, Alberto G. Ayala, Bogdan Czerniak	1998	44
12	Fluorocarbon Modified Low-Molecular-Weight Polyethylenimine for siRNA Delivery Bioconjugate Chemistry ·Mark E. Johnson, D. Judy Shon, Brian M. Guan, Joseph P. Patterson, Nathan J. Oldenhuis, Alexander C. Eldredge, Nathan C. Gianneschi, Zhibin Guan	2016	41
13	Physical properties and surface activity of surfactant‐like membranes containing the cationic and hydrophobic peptide KL₄ FEBS Journal ·A. Sáenz, Olga Cañadas, Luís A. Bagatolli, Mark E. Johnson, Cristina Casals	2006	40
14	Naloxone inhibits superoxide release from human neutrophils Life Sciences ·Cuthbert Simpkins, Nadine Ives, Elin A. Tate, Mark E. Johnson	1985	40
15	Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma Cancer ·Carsten G. H�ckel, Sabine Krueger, Hans-J�rgen Grote, Yumi Oshiro, Sherie Hodges, Dennis A. Johnston, Mark E. Johnson, Albert Roessner, Alberto G. Ayala, Bogdan Czerniak	2000	34
16	Dendritic peptide bolaamphiphiles for siRNA delivery to primary adipocytes Biomaterials ·Alexander C. Eldredge, Mark E. Johnson, Yang Cao, Lin Zhang, Can Zhao, Zhengxia Liu, Qin Yang, Zhibin Guan	2018	27
17	Effect of Surfactant Protein A on the Physical Properties and Surface Activity of KL4-Surfactant Biophysical Journal ·A. Sáenz, Olga Cañadas, Luís A. Bagatolli, Fernando Sánchez-Barbero, Mark E. Johnson, Cristina Casals	2006	27
18	The effect of enkephalins and prostaglandins on O2− release by neutrophils Journal of Surgical Research ·Cuthbert Simpkins, Sione T. Alailima, Elin A. Tate, Mark E. Johnson	1986	22
19	Malignant chondroblastoma presenting as a recurrent pelvic tumor with DNA aneuploidy and p53 mutation as supportive evidence of malignancy Skeletal Radiology ·Luan D. Truong, Frank E. Smith, Mary L. Ostrowski, Mark E. Johnson, Harlan J. Spjut, John Hicks	1999	20
20	Selective tumorigenesis in non-parenchymal liver epithelial cell lines by hepatocyte growth factor transfection Cancer Letters ·Mark E. Johnson, George Koukoulis, Kulvinder S. Kochhar, Chris Kubo, Toshikazu Nakamura, Anand Iyer	1995	19

About Mark E. Johnson

Mark E. Johnson is a scholar working on Pharmaceutical Science, Hepatology, Dermatology, Cancer Research and Rheumatology, having authored 32 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), Bone Tumor Diagnosis and Treatments (5 papers), Dendrimers and Hyperbranched Polymers (4 papers), Immunotherapy and Immune Responses (4 papers), Dermatology and Skin Diseases (3 papers), Liver physiology and pathology (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Pharmaceutical Science (395 citations), Dermatology (209 citations), Immunology (365 citations), Hepatology (95 citations) and Molecular Biology (693 citations). Mark E. Johnson has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Daniel Blankschtein, Sjoerd H. van der Burg, Grayson B. Lipford, Rienk Offringa, Cornelis J.M. Melief, Jan Nouta, Samir Mitragotri, Zhibin Guan, George Koukoulis and Anand Iyer. Their work appears in journals such as Journal of Pharmaceutical Sciences, Cancer, Life Sciences, Biophysical Journal and FEBS Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact